• Home
• Knowledge center
• Webinar: Pharmacovigilance and Risk Management in Innovative Therapies

Pharmacovigilance and Risk Management in Innovative Therapies: A Challenge in Drug Safety

The webinar discusses the evolving pharmacovigilance and risk management environment of innovative therapies, emphasizing safety challenges in cell, CAR T, and RNA-based treatments, as well as gaps in regulation and surveillance strategies.

Be part of it and remain ahead of drug safety: addressing the complexities of tomorrow’s therapies today!

Register here

On demand

1h

Pharma & Biotech

English

Register here

Share

\ \ X (Twitter) \ \ LinkedIn \ \ WhatsApp \ \ Copy link \ \ Mail

About the webinar

As innovative therapies like cell, CAR T, and RNA-based treatments transform modern medicine, they also present new and complex safety challenges.

This webinar delves into the critical aspects of pharmacovigilance and risk management necessary to support these advances. Participants will gain insight into the origin and impact of safety concerns in cell and CAR T therapies.

Pharmacovigilance has become an essential discipline to ensure the safety of patients receiving innovative therapies. We will also discuss how authorities are addressing these treatments to minimize the risks.

The session will also cover the ongoing revolution in RNA-based therapies, outlining their therapeutic potential alongside emerging safety risks. Attendees will learn about current pharmacovigilance strategies tailored to these novel products and explore future perspectives in managing evolving risks.

Designed for professionals in drug safety, regulatory affairs, and clinical development, this webinar offers a vital opportunity to stay informed and prepared in an ever-changing therapeutic landscape.

Register now

What you'll learn

• Discover strategic approaches to risk management in the development of innovative treatments.
• Understanding on the unique safety challenges associated with cell and CAR T therapies.
• Learn the fundamentals and mechanisms behind RNA-based therapeutic technologies.
• Identify key pharmacovigilance concerns specific to RNA-based therapies and how to address them.
• Prepare for the future of drug safety by recognizing evolving risks and opportunities in cutting-edge therapies.

Speakers

Join us as our expert speakers share valuable insights and practical knowledge drawn from extensive industry experience.

Don’t miss the opportunity to learn and engage with professionals in the field.

Dr. Almudena Del Castillo Saiz

Head of Drug Safety & Vigilance, QbD Group

Dr. Almudena del Castillo, a Medical Doctor and Specialist in Family and Community Medicine, is an expert in pharmacovigilance within the pharmaceutical industry.

With a strong interest in regulatory affairs and drug safety, she has held roles at major pharmaceutical companies like Pfizer. She later applied her combined scientific and business vision at leading life sciences consultancies, including Pharmalex and PLG, as VP of Sales and Business Development.

Currently, as Global Division Head of Drug Safety and Vigilance at QbD Group, she drives globally focused solutions in safety, regulatory compliance, and strategic medical affairs.

Anam Ahmad

Senior PV Associate

Anam holds a BSc in Pharmaceutical and Cosmetic Sciences and has developed a strong career in pharmacovigilance, supporting clinical trials, marketing authorisation applications, and post-marketing activities in the UK and internationally.

She acts as the UK QPPV and local pharmacovigilance contact, ensuring regulatory compliance and effective safety oversight. She brings broad expertise in pharmacovigilance and is recognized for her proactive, solutions-focused approach and strong commitment to medicine safety.

Dr. Laura Fragata Tavares

Pharmacovigilance Consultant

Dr. Laura Fragata holds a Doctor of Veterinary Medicine degree and is trained as a Qualification and Validation Coordinator. She began her career in quality assurance within the biopharmaceutical industry, working on medical device projects and ensuring compliance with industry standards.

Currently, Laura works in the pharmacovigilance department at our HQ in Belgium, where she supports various safety-related activities across different types of health products in both clinical and post-marketing settings.

Watch here

Submit your contact details to register to this webinar. Don’t miss out on valuable insights and actionable strategies from our industry experts.

First name*

Last name*

Role*

Please SelectC-level / VPDirector(Sr.) ManagerSpecialist/AnalystIntern/ApprenticeIndividual contributorOther

Department*

Please SelectStrategy & ManagementRegulatory & VigilanceQuality Assurance & ControlIT & Digital InnovationManufacturing & ProductionProduct DevelopmentResearch & InnovationClinical Affairs & OperationsMedical AffairsMarket AccessSales & MarketingHRProcurementOther

Professional Email*

Company name*

Industry *

Please SelectMedical DevicesIn Vitro DiagnosticsPharmaBiotechAnimal HealthService providerConsumer HealthOther

Country*

Please SelectAfghanistanÅland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAsia/Pacific RegionAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCote d'IvoireCroatiaCubaCuraçaoCyprusCzech RepublicDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEast TimorEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaEuropeFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern and Antarctic LandsGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinePanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRéunionRomaniaRussiaRwandaSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

Would you like a one-on-one with our team?*

Please SelectYesNo

Content Title

Content Type

Content Division

Content Industry

QbD Group is committed to protecting and respecting your privacy, and we’ll use your personal information to administer your account and to provide the products and services you requested from us.

•  Yes, I agree to receive personalized newsletters with market insights, invitations for exclusive events and educational webinars from the QbD Group.

• I consent to the privacy policy and understand that my personal data will be stored and processed. *

Upcoming webinars

From R&D to market IP and regulatory strategy across the product life cycle

Join this Biovia x Gevers x QbD Group webinar to explore product life cycle strategies, focusing on R&D, regulatory alignment, and Quality by Design insights for life sciences professionals.

Medical Devices

Read more

Nitrosamine Risk Assessment: Adapting to the Latest Regulatory Expectations

Manage the risk of nitrosamines in the pharmaceutical industry. Join our webinar and learn about regulation and risk analysis from experts.

Pharma & Biotech

Read more

From Strategy to First-in-Human: A Practical Roadmap for Biotech Development

Join our webinar to learn how to navigate nitrosamine risks and streamline your biotech development from early planning to first-in-human trials. Register now for expert insights.

Pharma & Biotech

Read more

AI in Life Sciences

Join our webinar with delaware on implementing compliant AI in life sciences. Learn best practices and avoid pitfalls in GxP environments from industry experts. Register now.

Software Solutions & Services

Read more

Discover all

We share the latest news

Staying on top of the latest in the life science industry can be a daunting task. This newsletter will keep you up-to-date with the latest news, blogs and webinars so you can keep ahead of the curve.

Subscribe to newsletter